Paige pricing
No price is published. The company was acquired by Tempus in August 2025 for a reported $81.25 million, with the stated rationale of building a large oncology foundation model, and Tempus now announces Paige products such as Paige Predict, launched in January 2026. The applications are also sold through partner platforms, including Leica Biosystems' Aperio AI Store. Which entity contracts and bills, whether the suites are sold standalone or bundled with Tempus testing, and what support commitments followed the change of ownership are not published.
How Paige pricing works
- Pricing model
- Not published; commercial structure now set within Tempus's portfolio.
- Business associate agreement
- Not published. The privacy policy describes provider customers directing the use of patient information, without naming HIPAA or a business associate agreement; which entity signs one under Tempus ownership is not stated.
Paige pricing against its alternatives
Published prices for Paige and the products closest to it. Each figure is as the vendor publishes it, in its own currency and billing unit.
- PPaigeNot published (owned by Tempus since August 2025)
- IIbex Medical AnalyticsNo published price
- PPathAINo published price
- MModella AIResearch use only, not commercially priced for clinical use
- PProsciaNo published price
- MMindpeakNo published price
- LLumeaDevices and consumables sold through a published online shop; software platform pricing not published
- LLeica Aperio iQC DXNo published price
- TTempusNo published price
Paige pricing, answered
How much does Paige cost?
Paige does not publish a price. The company was acquired by Tempus in August 2025 for a reported $81.25 million, with the stated rationale of building a large oncology foundation model, and Tempus now announces Paige products such as Paige Predict, launched in January 2026. The applications are also sold through partner platforms, including Leica Biosystems' Aperio AI Store.
Does Paige offer a business associate agreement?
Not published. The privacy policy describes provider customers directing the use of patient information, without naming HIPAA or a business associate agreement; which entity signs one under Tempus ownership is not stated.